NEW YORK (GenomeWeb) – ImaBiotech and iTeos Therapeutics today announced that they have received a two-year €800,000 grant ($867,544) from the Walloon Region of Belgium and Bpifrance to fund research characterizing the microenvironment of tumor tissues.

Belgian therapeutics firm iTeos will contribute immune-oncology animal models and tissue libraries for metabolite profiling using ImaBiotech's Multimaging combined mass spectrometry imaging and immunohistology technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.